A Novel Way to Decide on Ideal Treatment for Difficult PCa Cases

Share this content:

Investigators in Boston say that by measuring the androgen receptor signaling pathway they can decide on the ideal treatment for patients with metastatic prostate cancer that stops responding to initial therapy. John Schieszer has the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters